William L. Casley

930 total citations
24 papers, 422 citations indexed

About

William L. Casley is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, William L. Casley has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in William L. Casley's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). William L. Casley is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). William L. Casley collaborates with scholars based in Canada, United States and China. William L. Casley's co-authors include Mallé Jurima‐Romet, Rachel F. Tyndale, J. Steven Leeder, Andrea Gaedigk, Edward M. Sellers, Pollen Yeung, Thomas W. Moon, Rémy A. Aubin, Anna Hudson and E. Tackaberry and has published in prestigious journals such as Neurology, Toxicology and Applied Pharmacology and Genomics.

In The Last Decade

William L. Casley

24 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William L. Casley Canada 12 181 160 95 60 50 24 422
F.M. Farin United States 12 153 0.8× 164 1.0× 68 0.7× 17 0.3× 30 0.6× 13 446
Gaby‐Fleur Böl Germany 10 252 1.4× 59 0.4× 49 0.5× 26 0.4× 28 0.6× 12 558
Guiqing Liang United States 11 171 0.9× 58 0.4× 55 0.6× 38 0.6× 25 0.5× 21 484
Patson T. Nhamburo United States 11 243 1.3× 297 1.9× 143 1.5× 68 1.1× 32 0.6× 14 584
S. Monier France 6 484 2.7× 147 0.9× 61 0.6× 26 0.4× 26 0.5× 7 721
Tsuneo Wakabayashi Japan 11 201 1.1× 59 0.4× 71 0.7× 45 0.8× 25 0.5× 40 480
Kerstin Nilsson Sweden 9 244 1.3× 96 0.6× 58 0.6× 8 0.1× 22 0.4× 11 574
Christine Chapline United States 6 355 2.0× 52 0.3× 43 0.5× 32 0.5× 20 0.4× 7 708
Samantha L. Hoopes United States 14 183 1.0× 57 0.4× 109 1.1× 48 0.8× 20 0.4× 14 599
Nuno G. Machado Portugal 11 208 1.1× 49 0.3× 45 0.5× 16 0.3× 30 0.6× 12 428

Countries citing papers authored by William L. Casley

Since Specialization
Citations

This map shows the geographic impact of William L. Casley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Casley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Casley more than expected).

Fields of papers citing papers by William L. Casley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Casley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Casley. The network helps show where William L. Casley may publish in the future.

Co-authorship network of co-authors of William L. Casley

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Casley. A scholar is included among the top collaborators of William L. Casley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Casley. William L. Casley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeung, Pollen, et al.. (2008). HPLC assay with UV detection for determination of RBC purine nucleotide concentrations and application for biomarker study in vivo. Journal of Pharmaceutical and Biomedical Analysis. 47(2). 377–382. 41 indexed citations
2.
Yeung, Pollen, et al.. (2008). Pharmacokinetics and Metabolism of Diltiazem Following Multiple Doses:Comparing Normotensive Rat vs. Hypertensive Rat Models In vivo. Drug Metabolism Letters. 2(2). 146–150. 3 indexed citations
3.
Pereboev, Alexander, Nikolay Korokhov, Runtao He, et al.. (2007). Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells. Gene Therapy. 15(4). 298–308. 26 indexed citations
4.
Casley, William L., L.W. Whitehouse, Mary Alice Hefford, et al.. (2007). Cytotoxic Doses of Ketoconazole Affect Expression of a Subset of Hepatic Genes. Journal of Toxicology and Environmental Health. 70(22). 1946–1955. 7 indexed citations
5.
6.
Tackaberry, E., et al.. (2006). Accurate Determination of Zygosity in Transgenic Rice by Real-time PCR Does Not Require Standard Curves or Efficiency Correction. Transgenic Research. 15(2). 261–265. 33 indexed citations
7.
Kumar, Veena, et al.. (2005). Isolation and Characterization of a cDNA Clone Encoding One IgE-Binding Fragment of <i>Penicillium brevicompactum</i>. International Archives of Allergy and Immunology. 138(1). 12–20. 6 indexed citations
8.
Lorenzen, Angela, William L. Casley, & Thomas W. Moon. (2001). A Reverse Transcription–Polymerase Chain Reaction Bioassay for Avian Vitellogenin mRNA. Toxicology and Applied Pharmacology. 176(3). 169–180. 11 indexed citations
9.
Gaedigk, Andrea, William L. Casley, Rachel F. Tyndale, et al.. (2001). Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. Canadian Journal of Physiology and Pharmacology. 79(10). 841–847. 50 indexed citations
10.
Jurima‐Romet, Mallé, et al.. (2000). Evidence for the catalysis of Dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver. Toxicology in Vitro. 14(3). 253–263. 21 indexed citations
11.
Otto, Diana M. E., et al.. (1999). Regulation of Cytochrome P4501A Metabolism by Glutathione. Pharmacology & Toxicology. 84(5). 201–210. 4 indexed citations
12.
Otto, Diana M. E., Chandan K. Sen, William L. Casley, & Thomas W. Moon. (1997). Regulation of 3,3′,4,4′-Tetrachlorobiphenyl Induced Cytochrome P450 Metabolism by Thiols in Tissues of Rainbow Trout*. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 117(3). 299–309. 16 indexed citations
13.
14.
Casley, William L.. (1997). Differences in Caffeine 3-Demethylation Activity among Inbred Mouse Strains: A Comparison of HepaticCyp1a2Gene Expression between Two Inbred Strains. Fundamental and Applied Toxicology. 40(2). 228–237. 11 indexed citations
15.
Jurima‐Romet, Mallé, et al.. (1997). CYP2D6-related oxidation polymorphism in a Canadian Inuit population. Canadian Journal of Physiology and Pharmacology. 75(3). 165–172. 18 indexed citations
16.
Otto, Diana M. E., Chandan K. Sen, William L. Casley, & T. W. Moon. (1996). Glutathione regulates 3,3',4,4'-tetrachlorobiphenyl induced cytochrome P450 metabolism: evidence for a cross-talk between the two major detoxication pathways.. PubMed. 38(6). 1127–33. 6 indexed citations
17.
Jurima‐Romet, Mallé, et al.. (1995). Induction of CYP3A and associated terfenadineN-dealkylation in rat hepatocytes cocultured with 3T3 cells. Cell Biology and Toxicology. 11(6). 313–327. 11 indexed citations
18.
Casley, William L., Michael Allon, Hélène Cousin, et al.. (1992). Exclusion of linkage between hypokalemic periodic paralysis (HOKPP) and three candidate loci. Genomics. 14(2). 493–494. 13 indexed citations
19.
Casley, William L., Anna Hudson, E. Gordon Murphy, et al.. (1992). Linkage analysis of candidate loci in autosomal dominant myotonia congenita. Neurology. 42(8). 1561–1561. 7 indexed citations
20.
Casley, William L., Hélène Cousin, Anna Hudson, et al.. (1992). Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35.. PubMed. 51(3). 579–84. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.M. Farin Breakdown of academic impact, for papers by Gaby‐Fleur Böl Breakdown of academic impact, for papers by Guiqing Liang Breakdown of academic impact, for papers by Patson T. Nhamburo Breakdown of academic impact, for papers by S. Monier Breakdown of academic impact, for papers by Tsuneo Wakabayashi Breakdown of academic impact, for papers by Kerstin Nilsson Breakdown of academic impact, for papers by Christine Chapline Breakdown of academic impact, for papers by Samantha L. Hoopes Breakdown of academic impact, for papers by Nuno G. Machado
Rankless by CCL
2026